Page 2 of 6

Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial

New article on the treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial from the Lancet Infectious Diseases

Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial

International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections

New aeticle on the International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections from the journal Expert Review of Medical Devices

 

International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections

State health department validations of central line-associated bloodstream infection events reported via the National Healthcare Safety Network

New article on the State health department validations of central line-associated bloodstream infection events reported via the National Healthcare Safety Network from American Journal of Infection Control

State health department validations of central line-associated bloodstream infection events reported via the National Healthcare Safety Network

The Cost-effectiveness of Antimicrobial Lock Solutions for the Prevention of Central Line-Associated Bloodstream Infections

New article on The Cost-effectiveness of Antimicrobial Lock Solutions for the Prevention of Central Line-Associated Bloodstream Infections from Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

 

The Cost-effectiveness of Antimicrobial Lock Solutions for the Prevention of Central Line-Associated Bloodstream Infections

Catheter to Vessel Ratio App coming soon…

That’s right, Global Vascular Access, LLC & KJM Insights are currently developing a fully functional smartphone App and widget (Apple Watch, etc) that helps you, the clinician to determine the best catheter to vessel ratio (CVR) for your patients intravascular requirements, regardless of what brand of venous or arterial device you place – based upon the area consumed by the device within the vessel – PIVC, extended dwell, arterial catheter, midline, PICC, or CICC – even dialysis and tunneled/implanted catheters.

Our tool will work with all your brand catheters – to help you determine the most appropriate vessel and device size.

What’s even just as impressive is that it will be FREE for everyone.. yes, FREE! For both iOS and Android platforms. You will find it on both the Apple iStore and Google Play when released.. watch this space for updates!

We are taking the guesswork out of the equation, and making it quick and simple to determine results. The hard math is done for you behind the scenes. Just enter catheter and/or vessel sizes and CVR Tool will do the rest. How hard is that? Not at all, but its in the best interest in your patients health.

CVR Table